These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34861326)

  • 1. Elevation of inactive cleaved annexin A1 in the neocortex is associated with amyloid, inflammatory and apoptotic markers in neurodegenerative dementias.
    Chua XY; Chong JR; Cheng AL; Lee JH; Ballard C; Aarsland D; Francis PT; Lai MKP
    Neurochem Int; 2022 Jan; 152():105251. PubMed ID: 34861326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias.
    Chai YL; Lee JH; Chong JR; Ballard C; Francis PT; Kennedy BK; Arumugam TV; Chen CP; Aarsland D; Lai MKP
    J Neuroinflammation; 2023 May; 20(1):111. PubMed ID: 37158957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
    Ries M; Loiola R; Shah UN; Gentleman SM; Solito E; Sastre M
    J Neuroinflammation; 2016 Sep; 13(1):234. PubMed ID: 27590054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
    Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
    Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.
    Chong JR; Chai YL; Lee JH; Howlett D; Attems J; Ballard CG; Aarsland D; Francis PT; Chen CP; Lai MK
    J Alzheimers Dis; 2017; 56(1):157-166. PubMed ID: 27911312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.
    Bibl M; Mollenhauer B; Esselmann H; Lewczuk P; Klafki HW; Sparbier K; Smirnov A; Cepek L; Trenkwalder C; Rüther E; Kornhuber J; Otto M; Wiltfang J
    Brain; 2006 May; 129(Pt 5):1177-87. PubMed ID: 16600985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias.
    Datta A; Chai YL; Tan JM; Lee JH; Francis PT; Chen CP; Sze SK; Lai MKP
    Mol Brain; 2017 Aug; 10(1):36. PubMed ID: 28800743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia.
    McArthur S; Cristante E; Paterno M; Christian H; Roncaroli F; Gillies GE; Solito E
    J Immunol; 2010 Nov; 185(10):6317-28. PubMed ID: 20962261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer's Disease.
    Fraga VG; Magalhães CA; Loures CMG; de Souza LC; Guimarães HC; Zauli DAG; Carvalho MDG; Ferreira CN; Caramelli P; de Sousa LP; Gomes KB
    Neuroscience; 2019 Nov; 421():123-135. PubMed ID: 31654714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
    Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
    Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson's Disease Dementia.
    Lee JH; Francis PT; Ballard CG; Aarsland D; Kalaria RN; Wong PT; Chen CP; Lai MK
    J Parkinsons Dis; 2016 Oct; 6(4):733-739. PubMed ID: 27662332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
    Hansen D; Ling H; Lashley T; Foley JA; Strand C; Eid TM; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):143-156. PubMed ID: 32720329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction.
    Hase Y; Polvikoski TM; Firbank MJ; Craggs LJL; Hawthorne E; Platten C; Stevenson W; Deramecourt V; Ballard C; Kenny RA; Perry RH; Ince P; Carare RO; Allan LM; Horsburgh K; Kalaria RN
    Brain Pathol; 2020 Jan; 30(1):191-202. PubMed ID: 31357238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.
    Llorens F; Thüne K; Tahir W; Kanata E; Diaz-Lucena D; Xanthopoulos K; Kovatsi E; Pleschka C; Garcia-Esparcia P; Schmitz M; Ozbay D; Correia S; Correia Â; Milosevic I; Andréoletti O; Fernández-Borges N; Vorberg IM; Glatzel M; Sklaviadis T; Torres JM; Krasemann S; Sánchez-Valle R; Ferrer I; Zerr I
    Mol Neurodegener; 2017 Nov; 12(1):83. PubMed ID: 29126445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease.
    Walker L; Simpson H; Thomas AJ; Attems J
    Acta Neuropathol Commun; 2024 Feb; 12(1):28. PubMed ID: 38360761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Aβ phosphorylated at serine 8 (pAβ) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.
    Ashby EL; Miners JS; Kumar S; Walter J; Love S; Kehoe PG
    Neuropathol Appl Neurobiol; 2015 Jun; 41(4):428-44. PubMed ID: 25556395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoform-specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias.
    Low CYB; Lee JH; Lim FTW; Lee C; Ballard C; Francis PT; Lai MKP; Tan MGK
    Brain Pathol; 2021 Mar; 31(2):253-266. PubMed ID: 33128789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.